Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting IRVINGTON, NY--(Marketwire - March 12, 2009) - Electro-Optical Sciences, Inc. (EOS) (NASDAQ: MELA) today announced that additional data on MelaFind®, the company's non-invasive, point-of-care...

Electro-Optical Sciences Announces Positive Top-Line Results From Landmark MelaFind(R) Pivotal Trial IRVINGTON, NY--(Marketwire - February 13, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced positive top-line results of its pivotal trial of MelaFind, a non-invasive,...